In this article published in the October 2017 issue of PharmaTimes, we explore how medical device companies can strategically use their IP to achieve their commercial goals and maximise the rewards flowing from their products.
This article by Rebecca Baines and Christopher Leung explores how medical device companies can strategically use their IP to achieve their commercial goals and maximise the rewards flowing from their products. It was first published in the October 2017 issue of PharmaTimes and is republished with the kind permission of the editor.